Orsted OTC ( (DNNGY) ) has released its Q4 earnings. Here is a breakdown of the information Orsted OTC presented to its investors.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Orsted OTC is a prominent company in the renewable energy sector, specializing in the development, construction, and operation of offshore and onshore wind farms, solar farms, and energy storage facilities with a strong commitment to sustainability.
In its latest earnings report, Orsted OTC highlights its strategic and financial performance for 2024, noting a significant increase in installed renewable capacity and advancements in major projects across various regions.
The company reported an EBITDA of DKK 32.0 billion, with notable earnings from offshore sites and a strategic divestment program that generated DKK 22 billion. Despite challenges in the US projects, Orsted OTC maintained a focus on optimizing its assets and improving revenue capabilities.
Looking forward, Orsted OTC plans to continue its focus on strategic growth in attractive offshore wind opportunities and maintain a disciplined approach to capital allocation. The company aims for a significant increase in renewable capacity to 27.3 GW by 2027 while upholding strong sustainability commitments.
The management remains optimistic about Orsted OTC’s ability to navigate market challenges and achieve long-term growth, expecting an EBITDA of DKK 29-33 billion by 2026 with a robust strategy to enhance value creation in the renewable energy sector.